Paratek Pharmaceuticals has completed the acquisition of Optinose, valued at almost $330m, broadening its commercial product ...

Explore Novotech CEO John Moller's insights on the company's global expansion, commitment to diversity, and innovative ...

Evernorth said that through direct negotiations with Novo Nordisk and Eli Lilly, patients’ monthly copay costs for Wegovy ...

UK biopharmaceutical companies saw a surge in venture financing for innovator drugs in 2024, with double the total deal value ...

Orionis Biosciences has announced a multi-year partnership with Roche’s Genentech for small-molecule monovalent glue medicine ...

To overcome pharma logistics challenges with transporting an MS vaccine, an expert logistics provider was needed.

After the FDA asked for more clinical data in May 2025, Moderna has decided to resubmit the BLA later this year.

Eli Lilly and Company has received marketing authorisation from the Australian Therapeutic Goods Administration (TGA) for Kisunla.

Potential US pharma import tariffs could raise prices, stifle innovation, and revolutionise how the industry produces drugs.

We learn how the EU’s new Clinical Trial Regulation (CTR) and the CTIS platform are reshaping clinical trial approvals and ...

GSK will incorporate the findings into messaging that depemokimab patients will adhere to treatment better, ensuring better ...

Despite the boost to contributions, WHO has downsized its 2026-27 budget by over $1bn due to financial constraints.